BRK-B vs FNWB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FNWB exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. While the stock trades at a deep discount to book value (P/B 0.56) and shows impressive YoY revenue growth of 63.6%, these are overshadowed by negative ROE (-2.69%) and a profit margin of -6.92%. Furthermore, the dividend is unsustainable with a payout ratio of 107.69%, suggesting the company is paying out more than it earns. Despite a positive analyst target price, the deterministic health metrics signal high risk.
Compare Another Pair
Related Comparisons
BRK-B vs FNWB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and First Northwest Bancorp (FNWB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.